Class Action Lawsuit Filed Against Applied Therapeutics, Inc.:
The Schall Law Firm, a renowned national shareholder rights litigation firm, has announced that it is representing investors who purchased securities of Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The firm has filed a class action lawsuit against the Company for alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Background:
Applied Therapeutics is a biopharmaceutical company focused on the development and commercialization of therapeutic products for various diseases. During the Class Period, the Company made several public statements regarding its clinical trials and financial projections, which allegedly contained false and misleading information.
Allegations:
The Schall Law Firm alleges that Applied Therapeutics, through its executives and other representatives, made materially false and misleading statements regarding the Company’s clinical trials and financial projections. Specifically, the complaint alleges that Applied Therapeutics downplayed the risks associated with its clinical trials and overstated the likelihood of regulatory approval for its lead product.
Impact on Investors:
As a result of these alleged false statements, Applied Therapeutics’ securities traded at artificially inflated prices during the Class Period. When the truth was revealed, the price of Applied Therapeutics’ securities significantly declined, causing harm to investors.
Implications for the World:
The consequences of such securities fraud can extend beyond the affected investors. The lack of transparency and honesty in the financial markets can lead to a loss of trust and confidence among investors. Furthermore, it can deter potential investors from entering the market, thereby limiting the flow of capital and hindering economic growth.
What This Means for You:
If you purchased Applied Therapeutics securities between January 3, 2024, and December 2, 2024, you may be eligible to participate in the class action lawsuit. It is essential to contact a shareholder rights law firm, such as The Schall Law Firm, as soon as possible to discuss your legal rights and options.
Conclusion:
The filing of this class action lawsuit against Applied Therapeutics serves as a reminder of the importance of transparency and honesty in the financial markets. Investors rely on accurate information to make informed decisions, and any misrepresentation can lead to significant financial losses. If you believe you have been affected by securities fraud, it is crucial to seek the advice of a qualified attorney to protect your rights and interests.
- The Schall Law Firm has filed a class action lawsuit against Applied Therapeutics, Inc. for alleged securities fraud.
- The lawsuit alleges that the Company made false and misleading statements regarding its clinical trials and financial projections.
- The alleged false statements caused Applied Therapeutics’ securities to trade at artificially inflated prices during the Class Period.
- The consequences of such securities fraud can lead to a loss of trust and confidence in the financial markets and deter potential investors.
- If you purchased Applied Therapeutics securities between January 3, 2024, and December 2, 2024, you may be eligible to participate in the class action lawsuit.
